The Cancer Center Administration team provides centralized infrastructure and support that enables the City of Hope Comprehensive Cancer Center to function effectively, efficiently, and cohesively. Administration works with other Center leadership to foster collaborations, and support cancer focused research through infrastructure, pilot projects, and faculty recruitment. Administration's specific duties include: * Administrative planning to promote and facilitate scientific collaborations and interactions * Strategic planning leadership and implementation of initiatives * Management and evaluation of Cancer Center Membership * Fiscal control and management of Cancer Center accounts ensuring compliance with all COH institutional policies and federal requirements * Management, logistics support and documentation of senior leadership committees, retreats and programmatic meetings * Coordination of information technology required for internal and external data reporting *Coordination of planning and evaluation of Shared Resources * Management, processing and monitoring of CC pilot project competitions *Cataloguing of all CC programmatic meetings and retreats Recent accomplishments of the Administration Team include successful development of new Shared Resources and establishment of a new Shared Resources reporting system, review/restructure of membership, and completion of a new strategic plan. Funding is requested to cover a portion of the salary for these efforts and to cover a portion of the costs for the Cancer Center seminar series. The majority of the costs for Administration are covered by institutional funds. The Administration budget request represents 4.1% of the overall CCSG budget requested in this application.

Public Health Relevance

Cancer Center Administration provides centralized leadership and support for multiple functions including strategic planning, membership, pilot project competitions, educational seminars, senior leadership meetings and Shared Resources. This responsibility enhances the Cancer Center's dedication to providing a leadership structure which contributes to the coordination and collaboration of research efforts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA033572-31
Application #
8764861
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
31
Fiscal Year
2014
Total Cost
$76,392
Indirect Cost
$30,921
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Kingsmore, Kathryn M; Vaccari, Andrea; Abler, Daniel et al. (2018) MRI analysis to map interstitial flow in the brain tumor microenvironment. APL Bioeng 2:
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Wu, Chenkai; Ashing, Kimlin Tam; Jones, Veronica C et al. (2018) The association of neighborhood context with health outcomes among ethnic minority breast cancer survivors. J Behav Med 41:52-61
Wussow, Felix; Chiuppesi, Flavia; Meng, Zhuo et al. (2018) Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex. J Virol Methods 251:30-37
Wildes, Tanya M; Maggiore, Ronald J; Tew, William P et al. (2018) Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group. Support Care Cancer 26:3563-3570
Paz, Helicia; Joo, Eun Ji; Chou, Chih-Hsing et al. (2018) Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008. J Exp Clin Cancer Res 37:67
Slavin, Thomas P; Neuhausen, Susan L; Nehoray, Bita et al. (2018) The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer 17:235-245
Gast, Charles E; Silk, Alain D; Zarour, Luai et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4:eaat7828
Salgia, Ravi; Kulkarni, Prakash (2018) The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer. Trends Cancer 4:110-118
Yoon, Sorah; Wu, Xiwei; Armstrong, Brian et al. (2018) An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFR? Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma. Mol Ther Nucleic Acids 14:131-141

Showing the most recent 10 out of 1396 publications